Proceeds Purposes EBR Systems is using the funds to build on promising European clinical work; obtain CE Mark for the company’s proprietary wireless pacing system; obtain approval for a U.S. IDE (Investigational Device Exemption) clinical study; and complete development of its second generation system that is smaller and more energy efficient.